Daniel Halpern

Chief Executive Officer at InSitu Biologics.

Raised on InSitu Biologics filings

$1.3M

of $3.4M offered across 1 Form D filing

Company

Biotech · Oakdale, MN

Multi-day nerve block injection for post-surgical pain

Multi-day nerve block injection for post-surgical pain

InSitu Biologics Form D filings
Filed	Security	Sold of offered	Filing
Oct 14, 2026	Debt	$1.3M/ $3.4M	Form D/A

Also named on InSitu Biologics filings